Investigation update: Manufacturer settles approximately 4,000 Pradaxa lawsuits for $650 million

CLEVELAND - The German-based manufacturer of the popular blood thinner Pradaxa will pay $650 million to approximately 4000 patients to settle injury lawsuits.

Boehringer Ingelheim says it settled the claims to "avoid the distraction and uncertainty of lengthy litigation." 

Most patients complaints related to claims the company failed to adequately warn patients about the risk of internal bleeding. 

In February, an exclusive NewsChannel5 investigation revealed Pradaxa is the most complained about drug in the United States.

Related: Investigation: Pradaxa most complained about U.S. drug; blamed for deaths, life-threatening injuries

Our research found more complaints were filed with the FDA about Pradaxa than any other prescription drug in both 2011 and 2012.

Since it was approved by the FDA in 2010, Pradaxa has been blamed for 1,158 U.S. deaths and 12,494 serious injuries, according to Tom Moore, the senior scientist for drug safety and policy at the Institute for Safe Medication Practices. The ISMP is a non-profit organization that monitors FDA reports.

Pradaxa is used to treat atrial fibrillation, a heart condition that significantly increases the risk of stroke.

Print this article Back to Top